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ABSTRACT 
Objective: Gastro-oesophageal reflux disease (GERD) is defined as the backward flow of gastric contents into the oesophagus. A small amount of 
reflux occurs in normal individuals. It is a common disease with a prevalence as high as 10% - 20% in the western world. The disease may 
develop typical, atypical oesophageal and extra-oesophageal symptoms, complications, and can adversely affect an individual's quality of life. 
Management of GERD may involve lifestyle modification, medical therapy with PPIs, and anti - reflux surgery. But this is having adverse effects. 
So, the present study aims to assess the safety and efficacy of unani formulation in the treatment of GERD. 
 Material & Methods: We conducted this study on ten clinically diagnosed cases of GERD attending the Moalejat OPD at AKTCH, AMU Aligarh. 
Results: All the symptoms like heartburn, regurgitation, nausea, water brash, sleeplessness were significantly improved after the 45 days 
treatment with this Unani formulation. The result was analyzed and shown on Likert’s scale. 
Conclusion: The preliminary findings indicate that this Unani drug formulation is effective in patients with GERD. 
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Gastroesophageal reflux disease (GERD) is defined as 
symptoms and/ or complications resulting from reflux of 
gastric contents into the oesophagus and more proximal 
structures.1It is the most common oesophageal disorder, 
accounting for nearly 75% of all patients with oesophageal 
disorder. Transient lower esophageal sphincter relaxation is 
one of the most important causes for GERD.2 
GERD is prevalent worldwide, and the disease burden may 
be increasing. Prevalence estimates show considerable 
geographic variation, but only East Asia shows ratings 
consistently lower than 10%.3  
Monozygotic and dizygotic twins showed that genetic factors 
might contribute by 31% to the etiology of typical 
GERD.4Although genetic factors are involved, reflux is likely 
to be caused mainly by environmental factors.4 Obesity has 
recently been established as a risk factor of the internal 
environment, particularly among women5,6. External 
environmental factors include various exposures related to 
lifestyle, tobacco, smoking, alcohol drinking, coffee, and tea 
consumption, as well as regular use of aspirin and other non-
steroidal anti-inflammatory drugs, have all been proposed to 
be risk factors for reflux. 7,5,8  
Two cardinal esophageal symptoms signalize the GERD, i.e., 
heartburn, a burning sensation in the retrosternal and 
regurgitation, a perception of the flow of gastric contents 
into the mouth or hypopharynx. The prevalence of these two 
symptoms is 75% to 98% and 48% to 91% respectively. 
Above two symptoms can diagnose GERD without the need 
for endoscopy. 2 
Extra-esophageal symptoms such as non-cardiac chest 
(epigastric) pain, dental erosion, cough, laryngitis, and 
asthma are associated with but are not specific for GERD. It is 
also commonly associated with lower quality of life, poor 
quality of sleep, and decreased work productivity. 
Complications of GERD include reflux esophagitis (most 
often), esophageal stricture, Barrett’s esophagus, and 
esophageal adenocarcinoma 9, 10 
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 In a significant proportion of patients, symptom control and 
maintained quality of life can only be attained by either 
continuous proton pump inhibitors (PPIs) therapy or 
antireflux surgery (ARS), both in the short and long term.11,12 
,13,14 
Unani Description: 
GERD is a new term in this era, classical literature does not 
give the description of term on one hand, but the clinical 
features mentioned under the headings of sue hazm 
(Dyspepsia), bad hazmi (Indigestion), Hazm-ki-khraabi 
(Digestion disorder) in various books correspond with the 
signs and symptoms of GERD.15, 16, 17, 18 
Some scholars described the term Zauf-e-meda, Zauf-e-Hazm, 
Sue-Hazm (Dyspepsia) and Tukhma (Indigestion) in 
agglomeration,15 in which deleterious effects occur in the 
process of digestion of food. Food particles remain in the 
stomach and become the cause of nausea, abdominal pain, 
vomiting, belching, flatulence, water brash, heartburn, 
etc.15,17 
Its common causes include malfunctioning of the stomach, 
the diet has taken disproportionately, and food particles are 
not chewed congruously. While alcohol, tobacco, tea, coffee, 
ice cubes etc if taken in inadequate amount may be its rare 
causes. Sometimes, it occurs due to heavy physical and 
mental work, anxiety and depression.15, 16. 
Unani scholars have been treating this disease since ages. A 
large number of single and compound drugs have been 
documented for their efficacy in heartburn, regurgitation, 
dyspepsia, etc. This unani formulation contains various 
ingredients like heel kalaan (Amomum 
subulatum),tabaasheer (Bambusa arundinacea), kishneez 
khusk (Coriandrum sativum), gul-e-surkh (Rosa damascene) 
and baadiyaan (Foeniculum vulgare) all in equal amount. It is 
mainly used as Dafa e humoozat e meda. So present case 
series was carried out with the aim to explore the effect of 
this unani formulation on patients with GERD. 
MATERIAL AND METHODS 
Informed consent was taken from all the patients. The study 
was conducted on the patient attending Moalejat OPD-4 at 
Ajmal Khan Tibbiya College & Hospital, AMU, Aligarh.  
Intervention 
We enrolled ten patients in this case series. The Unani 
formulation was supplied in a powdered form and given to 
the patients of GERD twice daily after the meal in a dose of 6 
gram for 45 days with fortnightly follow up. Patients were 
also advised lifestyle modifications. Diagnosis was made on 
the basis of clinical symptoms compatible with the classical 
description of the disease.  
Case Presentations 
Case 1: A 42-year-old female, housewife came to Moalejat 
OPD of AKTCH AMU with the complaints of nausea, vomiting, 
belching, heartburn, water brash, pain in the epigastric 
region. She was advised to take the formulation along with 
dietary and lifestyle modifications. She got alleviation in her 
clinical features after 45 days of treatment. 
Case 2: A newly married 20 years old female visited Moalejat 
OPD of AKTCH AMU with the chief complaints of 
regurgitation, heartburn, epigastric pain, loss of appetite. 
After taking proper history, it was found that she was fond of 
taking coffee and spicy foods. Patient was advised to stop 
drinking coffee and also to take easily digestible and non 
spicy diet during the course of the treatment with test drug 
formulation. Subsequently, she got relief in all the symptoms 
after 45 days of treatment. 
Case 3: A 36-year-old male, a businessman came with 
complaints of restlessness, heartburn, water brash, anorexia, 
epigastric pain. On taking the history, it was found that he 
was in stress for some family problem. He was advised to 
take test formulation. After 45 days of treatment, he got 
subsequent dilution in his symptoms. 
Case 4: A 26-year-old married woman came to OPD with the 
chief complaints of, flatulence, epigastric pain, regurgitation, 
nausea, water brash. We advised her to take the test 
formulation. After 45 days of treatment, she reported 
gradual relief in symptoms. 
Case 5: A 58 years old female patient came to OPD with 
complaints of regurgitation, heartburn, sore throat along 
with a history of acid reflux into the mouth for two years. On 
the per abdomen, tenderness of mild grade was found in the 
epigastric region. After 45 days of treatment with Unani 
formulation, she got partial relief in her symptoms. 
Case 6: A 22 years old female student having complaints of 
mild regurgitation, water brash, nausea. She was fond of 
eating junk food. We advised her to quit junk food and to 
take easily digestible diet along with test formulation. There 
was found gradual easement in her symptoms on 2nd follow 
up. 
Case 7: A 53-year-old male, serviceman came to OPD with 
the complaints of heartburn, regurgitation, nausea, sore 
throat, epigastric pain. On investigation, it was found that he 
was on anxiolytics for seven months. He was advised to 
continue the same treatment and to take test formulation. 
After 45 days, his symptoms were found mitigated except 
regurgitation. 
Case 8: A 33-year-old male patient visited OPD with the 
complaints of nausea, heaviness in the abdomen after meal, 
regurgitation. He was found alcoholic on the investigation. 
We advised him to stop drinking alcohol and treat him with 
the test formulation for 45 days. He got partial relief in 
symptoms. 
Case 9: A 26-year-old male presented the OPD with 
complaints of acid reflux into the mouth, pain in the 
epigastric region, and nausea. He takes tea seven times per 
day. We advised him to reduce the number of cups per day 
and treat him with test formulation. After treatment, he 
reported a subsequent reduction in his symptoms. 
Case 10: A 40-year-old male visited OPD with the complaints 
of regurgitation, heartburn, water brash. He was advised to 
take Unani formulation. He got relief in all the symptoms 
after the completion of the trial. 
RESULT 
Based on the clinical symptoms, ten cases were analyzed. It 
was found that regurgitation and heartburn were prominent 
symptoms in all cases. Whereas nausea, water brash, 
epigastric pain and sleeplessness were the associated 
symptoms. After 45 days of treatment, patient found 
alleviation in the symptoms which were analyzed and graded 




Zafar et al                                                                                                              Journal of Drug Delivery & Therapeutics. 2019; 9(3-s):754-757 
ISSN: 2250-1177                                                                                  [756]                                                                                 CODEN (USA): JDDTAO 
 Grading of Symptoms on Likert Scale 
S.No. Regurgitation Heartburn Nausea Water brash Epigastric pain 
P1 P2 P1 P2 P1 P2 P1 P2 P1 P2 
1. 0 0 2 1 2 0 1 0 1 0 
2. 1 0 2 0 1 0 0 0 2 0 
3. 0 0 3 1 0 0 1 0 2 0 
4. 2 0 0 0 3 1 2 0 2 0 
5. 3 2 2 1 0 0 0 0 1 0 
6. 1 0 0 0 2 0 2 0 0 0 
7. 3 1 2 0 2 0 0 0 2 0 
8. 3 2 2 1 2 1 0 0 0 0 
9. 0 0 0 0 2 1 3 1 2 0 
10. 1 0 1 0 0 0 2 0 0 0 
0=Nil, 1=Mild, 2=Moderate, 3=Severe , P1=Pre-treatment P2=Post-treatment 
 
Composition of Test Drug Formulation 
S.No. Drug name Botanical name Medicinal properties 21,22 
1. Heel kalaan Amomum subulatum Stomachic, antiemetic, antibilious, astringent, 
alexipharmic; used for the treatment of indigestion, 
biliousness, abdominal pains, vomiting, in congestion 
of the liver. Pericarp-in headache and stomatitis. 
2. Tabaasheer Bambusa arundinacea stomachic, antiemetic, desiccant, absorbs the 
dampness of stomach. 
3. Gul-e-surkh Rosa damascene  Desiccant, astringent to stomach muscle, analgesic, 
resolvent, cardiac tonic, laxative. 
4. Kishneez khushk Coriandrum sativum Stomachic, carminative, anti-inflammatory, diuretic, 
hypoglycemic, analgesic, antispasmodic. Used in 
dyspepsia and gastroenteritis. 
5. Baadiyan Foeniculum vulgare Carminative,stomachic,antispasmodic, 
emmenagogue, galactagogue, anti-inflammatory, 
diuretic. Relieves bloating, nausea, settles the 
stomach, and stimulates the appetite. Also used in 
amenorrhoea and enuresis. 
 
DISCUSSION 
GERD symptoms have a profound impact on health-related 
quality of life. So this case series was designed to determine 
the effect of this unani formulation in the treatment of GERD. 
In the present study, almost all the patients showed a good 
response during and after the treatment of 45 days, which 
was analyzed and shown on Likert’s scale. 
Almost all the patients have chief complaints of regurgitation 
and heartburn along with associated symptoms of nausea, 
vomiting, water brash, restlessness, and sore throat. Overall 
symptoms were reduced to the nadir in most of the patients, 
whereas partial relief in regurgitation was noted in 2 
patients. And incomplete relief was found in heartburn in 3 
patients.  
During the entire case series, not a single case reported any 
adverse event. Thus validating the formulation as 
significantly effective in long as well as short term 
management of GERD with maximum socioeconomic 
advantage. 
The drug regimen also shows the anxiolytic effect as it 
lowers the anxiety of the patient, this may be due to the 
presence of khishnez and gul e surkh .Kishneez (Coriandrum) 
possesses properties like analgesic, stomachic, brain tonic, 
cardiac tonic, whereas Gul e surkh (Rosa damascene) is 
analgesic, resolvent, and cardiac tonic. The formulation is 
also found effective as an appetizer and digestive, which is 
due to the presence of digestive and stomach tonic drugs 
present in it. 
CONCLUSION 
Given the findings of result and discussion, it can be 
concluded that the test formulation provided significant 
improvement in the sign and symptoms of the patient of 
GERD. It is economically fair treatment without any non-
compliance. Therefore further studies may be performed to 
know the effectiveness & mechanism of action of this 
formulation in GERD with a control group on a large scale. 
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